In 2013, two groups identified p.Arg47His (R47H) within the triggering receptor expressed on myeloid cells 2 (TREM2) gene as a lateonset AD risk variant; the independent studies were published in back-to-back publications in the New England Journal of Medicine [26, 27]. Here, TREM2 is linked to Alzheimer disease.